Exact Sciences Corp. added two new faces to its board of directors.
The Marlborough-based cancer gene testing firm named Foley & Lardner LLP partner James Connelly and Procter & Gamble‘s North American pharmaceuticals VP and general manager Katherine Napier to its board.
Both have connections to the local medical device industry, through their tenures as directors at Third Wave Technologies Inc. until its acquisition by Hologic last year.
Exact Sciences also said board member Michael Singer will not stand for re-election after his term expires in July, to spend more time in his role as CEO at BrainScope Company Inc.
